Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas

Pancreas

Volumn 40, Issue 4, 2011, Pages 588-594

  Karasaki, Hidenori ^a   Mizukami, Yusuke ^b   Tokusashi, Yoshihiko ^c   Koizumi, Kazuya ^b   Ishizaki, Akira ^a   Imai, Kouji ^a   Yoshikawa, Daitaro ^a   Kino, Shuichi ^a   Sasajima, Junpei ^b   Tanno, Satoshi ^d   Matsumoto, Kakuya ^a   Miyokawa, Naoyuki ^c   Kono, Toru ^a   Kohgo, Yutaka ^b   Furukawa, Hiroyuki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Division of Gastroenterology and Hematology/Oncology   (Japan)

^c Department of Surgical Pathology ^*  (Japan)

^d Kotoni Royal Hospital   (Japan)

Author keywords

Intraductal papillary mucinous neoplasm of the pancreas; minimally invasive carcinoma; mucin phenotype; severely dysplastic lesion

Indexed keywords

MUCIN 1; MUCIN 2;

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MURAL NODULE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DISEASE; PANCREAS RESECTION; PANCREATIC INTRADUCTAL DYSPLASIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE SECTION;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-1; MUCIN-2; MUCINS; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS;

EID: 79955050772     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31820d1a03     Document Type: Article

References (20)

1. Hruban RH, Pitman MB, Klimstra DS. Tumor of the Pancreas (AFIPAtlas of Tumor Pathology. Fourth Series. Fascicle 6). Washington, DC: American Registry of Pathology; 2007:75-110.
2. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003; 90:1244-1249. (Pubitemid 37330429)
3. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007; 246:644-651; discussion 51-54. (Pubitemid 47480616)
4. Nara S, Onaya H, Hiraoka N, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009; 38:8-16.
5. Kawai M, Uchiyama K, Tani M, et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities. Arch Surg. 2004; 139:188-192. (Pubitemid 38174715)
6. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6:17-32.
7. Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008; 57:339-343. (Pubitemid 351288099)
8. Kobayashi G, Fujita N, Noda Y, et al. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. J Gastroenterol. 2005; 40:744-751. (Pubitemid 41349087)
9. Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008; 57:1561-1565.
10. Yamao K, Ohashi K, Nakamura T, et al. The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology. 2000; 47:1129-1134.
11. Sugiyama M, Suzuki Y, Abe N, et al. Management of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2008; 43:181-185. (Pubitemid 351486678)
12. Ishida M, Egawa S, Aoki T, et al. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas. 2007; 35:348-352. (Pubitemid 350307378)
13. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005; 447:794-799. (Pubitemid 41728866)
14. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004; 28:839-848. (Pubitemid 38856838)
15. Ogawa H, Itoh S, Ikeda M, et al. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology. 2008; 248:876-886.
16. Chadwick B, Willmore-Payne C, Tripp S, et al. Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas. Appl Immunohistochem Mol Morphol. 2009; 17:31-39.
17. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002; 15:1087-1095.
18. Fukushima N, Mukai K, Sakamoto M, et al. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases. Virchows Arch. 2001; 439:6-13. (Pubitemid 32662512)
19. Hibi Y, Fukushima N, Tsuchida A, et al. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2007; 34:197-204. (Pubitemid 46294795)
20. Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002; 2:484-490. (Pubitemid 36151345)